[Treatment of acromegaly by dibromoergocryptine and cyproheptadine (author's transl)(proceedings)].
D000172:Acromegaly / Q000097:blood / Q000188:drug therapy; D001794:Blood Pressure; D001971:Bromocriptine / Q000627:therapeutic use*; D003533:Cyproheptadine / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D008297:Male; D011388:Prolactin / Q000097:blood
D004873:Ergolines; D003533:Cyproheptadine; D001971:Bromocriptine; D011388:Prolactin; D013006:Growth Hormone
Effects du traitement par la dibromoergocryptine (CB 154) et par la cyproheptodine dans l'acromégalie